GOCO SEC Filings - GoHealth, Inc.- Annual Report, Proxy Statement, Prospectus

Basic Stats

CIK

1808220

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to GoHealth, Inc.

SEC Filings (Chronological Order)

This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.

August 19, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 19, 2025 GoHealth, Inc. (Exa UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 19, 2025 GoHealth, Inc.
August 12, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
August 7, 2025	EX-10.2	Amendment No. 14 to Credit Agreement, dated as of August 6, 2025, by and among Norvax, LLC, as borrower, Blizzard Midco, LLC, the lenders party thereto, and Blue Torch Finance, LLC, as administrative agent and collateral agent (including Annex A which is a conformed version of the Credit Agreement). amendmentno14tocreditagr 1 AMENDMENT NO. 14 TO THE CREDIT AGREEMENT AMENDMENT NO. 14 TO THE CREDIT AGREEMENT, dated as of August 6, 2025 (this “Amendment”), by and among Blizzard Midco, LLC, a Delaware limited liability company (“Holdings”), Norvax, LLC, a Delaware limited liability company (the “Borrower”), the Lenders party hereto (constituting the Required Lenders, all of the Revolving Lenders
August 7, 2025	EX-10.1	Superpriority Senior Secured Credit Agreement, dated as of August 6, 2025, by and among Norvax, LLC, as borrower, Blizzard Midco, LLC, the lenders party thereto, and Blue Torch Finance, LLC, as administrative agent and collateral agent. superpriorityseniorsecur Execution Version SUPERPRIORITY SENIOR SECURED CREDIT AGREEMENT dated as of August 6, 2025, among BLIZZARD MIDCO, LLC, as Holdings, NORVAX, LLC, as the Borrower, The LENDERS Party Hereto, and BLUE TORCH FINANCE, LLC, as Administrative Agent and Collateral Agent i TABLE OF CONTENTS Page ARTICLE I DEFINITIONS .
August 7, 2025	EX-99.1	Strategic Capital and Governance Actions Exhibit 99.1 GoHealth Announces Strategic Capital and Governance Actions to Support Long-Term Value Creation and Reports Second Quarter 2025 Results CHICAGO, August 7, 2025 — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced the execution of strategic capital and governance actions that a
August 7, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 6, 2025 GoHealth, Inc. (Exac UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 6, 2025 GoHealth, Inc.
July 18, 2025	S-8	As filed with the Securities and Exchange Commission on July 18, 2025 As filed with the Securities and Exchange Commission on July 18, 2025 Registration No.
July 18, 2025	EX-FILING FEES	Filing Fee Table Exhibit 107 CALCULATION OF FILING FEE TABLE FORM S-8 (Form Type) GOHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Table I: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Class A Common Stock, par value $0
June 30, 2025	EX-10.1	Amendment No. 13 to Credit Agreement, dated as of June 30, 2025, by and among Norvax, LLC, as borrower, Blizzard Midco, LLC, the lenders and issuing banks party thereto, and Blue Torch Finance, LLC, as administrative agent and collateral agent (including Annex A which is a conformed version of the Credit Agreement). EXECUTION VERSION 1 AMENDMENT NO. 13 TO THE CREDIT AGREEMENT AMENDMENT NO. 13 TO THE CREDIT AGREEMENT, dated as of June 30, 2025 (this “Amendment”), by and among Blizzard Midco, LLC, a Delaware limited liability company (“Holdings”), Norvax, LLC, a Delaware limited liability company (the “Borrower”), the Lenders party hereto (constituting the Required Lenders, all of the Revolving Lenders and all
June 30, 2025	EX-99.1	GoHealth Secures Amended Credit Agreement Highlighting Broad Based Support from Stakeholders GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace, today announced it has entered into an amendment with its lenders under the Company’s EX-99.1 3 pressreleaseissuedbygohe.htm EX-99.1 GoHealth Secures Amended Credit Agreement Highlighting Broad Based Support from Stakeholders GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace, today announced it has entered into an amendment with its lenders under the Company’s existing credit agreement in order to, among other things, provide covenant adjustments as well as exte
June 30, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 30, 2025 GoHealth, Inc. (Exact UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 30, 2025 GoHealth, Inc.
June 20, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 18, 2025 GoHealth, Inc. (Exact UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 18, 2025 GoHealth, Inc.
May 16, 2025	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: March 31, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition
May 16, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
May 13, 2025	EX-99.1	First Quarter Highlights Exhibit 99.1 GoHealth Reports First Quarter 2025 Results CHICAGO, May 13, 2025 — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three months ended March 31, 2025. First Quarter Highlights •First quarter 2025 net revenues of $221.0 million, a 19.1% increase com
May 13, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 13, 2025 GoHealth, Inc.
April 28, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 28, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 7, 2025	EX-10.2	Letter Agreement, dated as of April 1, 2025, by and among Vijay Kotte and GoHealth, Inc. GoHealth 222 Merchandise Mart Plaza, Ste 1750 Chicago, IL 60654 April 1, 2025 Vijay Kotte Re: Retention Agreement Dear Vijay: This letter (the “Letter Agreement”) sets forth the terms of a retention award (the “Retention Award”) granted by GoHealth, Inc.
April 7, 2025	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 1, 2025 GoHealth, Inc.
April 7, 2025	EX-10.1	First Amendment to Employment Agreement, dated as of April 1, 2025, by and among Vijay Kotte, GoHealth, Inc. and GoHealth Holdings, LLC FIRST AMENDMENT TO EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) by and between GoHealth, Inc.
March 6, 2025	EX-FILING FEES	Filing Fee Table Exhibit 107 CALCULATION OF FILING FEE TABLE FORM S-8 (Form Type) GOHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Table I: Newly Registered Securities Plan Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Amended and Restated 2020 Incentive
March 6, 2025	S-8	As filed with the Securities and Exchange Commission on March 6, 2025 As filed with the Securities and Exchange Commission on March 6, 2025 Registration No.
February 27, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2025 GoHealth, Inc.
February 27, 2025	EX-19.1	GoHealth, Inc. Insider Trading Compliance Policy GOHEALTH, INC. INSIDER TRADING COMPLIANCE POLICY (As of February 25, 2025) This Insider Trading Compliance Policy (this “Policy”) consists of seven sections: • Section I provides an overview; • Section II sets forth the policies of the Company prohibiting insider trading; • Section III explains insider trading; • Section IV consists of procedures that have been put in place by the Company to preve
February 27, 2025	EX-21.1	Subsidiaries of the Registrant Exhibit 21.1 Subsidiaries of GoHealth, Inc. Legal Name Jurisdiction of Incorporation or Organization GoHealth Holdings, LLC Delaware, USA Blizzard Midco, LLC Delaware, USA Norvax, LLC Delaware, USA GoHealth, LLC Delaware, USA Connected Benefits, LLC Delaware, USA GoHealth, s.r.o. Slovakia ETQ Holdings, LLC Delaware, USA e-TeleQuote Insurance, Inc. Florida, USA ETeleQuote (Private) Limited Pakistan
February 27, 2025	EX-99.1	Fourth Quarter Highlights Exhibit 99.1 GoHealth Reports Strong Fourth Quarter and Fiscal Year 2024 Results, Driven by a Successful Annual Enrollment Period CHICAGO, February 27, 2025 — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and twelve months ended December 31, 2024. Fourt
February 27, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
November 7, 2024	EX-10.6	Amended and Restated Credit Agreement, dated as of November 4, 2024, by and among Blizzard Midco, LLC, Norvax, LLC, the lenders party thereto, the issuing banks party thereto and Blue Torch Finance, LLC, as administrative agent and collateral agent Annex A to Amendment and Restatement Agreement #97964454v11 4160-2903-6116.9 Exhibit A to Amendment No. 11 CREDIT AGREEMENT dated as of September 13, 2019, as amended by Amendment No. 1, dated as of March 20, 2020, Incremental Facility Agreement and Technical Amendment No. 2, dated as of May 7, 2020, Incremental Facility Agreement No. 3, dated as of June 11, 2020, Amendment No. 4 to Credit Agreeme
November 7, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
November 7, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 7, 2024 GoHealth, Inc.
November 7, 2024	EX-99.1	Third Quarter Highlights Exhibit 99.1 GoHealth Reports Third Quarter 2024 Results CHICAGO, November 7, 2024 — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and nine months ended September 30, 2024. Third Quarter Highlights •Third quarter 2024 net revenues of $118.3 million, a $
November 7, 2024	EX-10.3	Amendment No. 12 to the Credit Agreement dated as of October 15, 2024, among Norvax LLC, as borrower, Blue Owl 1 Execution Version AMENDMENT NO. 12 TO THE CREDIT AGREEMENT AMENDMENT NO. 12 TO THE CREDIT AGREEMENT, dated as of October 15, 2024 (this “Agreement”), by and among each of the Lenders signatory hereto constituting the Required Lenders (each as defined in the Credit Agreement, as defined below), the Borrower (as defined below), Holdings (as defined below), each other Guarantor (as defined in the C
November 7, 2024	EX-10.5	Amendment and Restatement Agreement, dated as of November 4, 2024, by and among Blizzard Midco, LLC, Norvax, LLC, the lenders party thereto, the issuing banks party thereto, Blue Owl Capital Corporation, as the predecessor agent, and Blue Torch Finance, LLC, as administrative agent and collateral agent 1 4139-1714-6964 Execution Version AMENDMENT AND RESTATEMENT AGREEMENT TO THE CREDIT AGREEMENT AMENDMENT AND RESTATEMENT AGREEMENT TO THE CREDIT AGREEMENT, dated as of November 4, 2024 (this “Agreement”), by and among the persons signatory hereto as Refinancing Term Lenders (the “Refinancing Term Lenders”), each of the other Lenders party hereto, the Borrower (as defined below), each Guarantor (as defined in the Credit Agreement) as of the date hereof, Blue Owl Capital Corporation (the “Predecessor Agent”) and Blue Torch Finance, LLC (“Blue Torch”), in its capacities as the administrative agent and collateral agent (as successor in interest to the Predecessor Agent) (in such capacities, the “Administrative Agent”).
November 7, 2024	EX-10.4	Consent Letter to the Credit Agreement, dated as of September 13, 2024, by and among the Borrower, each other Guarantor, Holdings, Blue Owl Cap Execution Version CONSENT LETTER TO THE CREDIT AGREEMENT CONSENT LETTER TO THE CREDIT AGREEMENT, dated as of September 13, 2024 (this “Agreement”), by and among the Borrower (as defined below), each other Guarantor (as defined in the Credit Agreement (as defined below)) as of the date hereof, Holdings (as defined below), Blue Owl Capital Corporation, in its capacity as the administrative agent (in such capacity, the “Administrative Agent”), and each of the Lenders signatory hereto constituting the Consenting Term Lenders (as defined in Amendment No.
October 10, 2024	EX-99.1	Brendan Shanahan Appointed Chief Financial Officer of GoHealth, Bringing Decades of Leadership in Healthcare and Financial Strategy CHICAGO, October 10, 2024 /Globe Newswire/ — GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace and shanahanprfinal2x101020 Brendan Shanahan Appointed Chief Financial Officer of GoHealth, Bringing Decades of Leadership in Healthcare and Financial Strategy CHICAGO, October 10, 2024 /Globe Newswire/ — GoHealth, Inc.
October 10, 2024	EX-10.1	Employment Agreement, dated as of October 4, 2024, by and among Brendan Shanahan, GoHealth, Inc. and Norvax, LLC shanahanbrendanemployme 1 Employment Agreement This Employment Agreement (the “Agreement”), entered into as of October 4, 2024 is made by and between Brendan Shanahan (the “Executive”), and GoHealth, Inc.
October 10, 2024	EX-10.2	Employment Agreement, dated as of October 4, 2024, by and among Katherine O’Halloran and Norvax, LLC ohallorankatherinecaoem 1 Amended and Restated Employment Agreement This Amended and Restated Employment Agreement (the “Agreement”), entered into as of October 4, 2024 is made by and between Katherine O’Halloran (the “Executive”), Norvax, LLC, a Delaware limited liability company (together with the Affiliates of Norvax as may employ the Executive from time to time, and any successor(s) thereto, the “Company”).
October 10, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 4, 2024 GoHealth, Inc. (Exa UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 4, 2024 GoHealth, Inc.
October 1, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 30, 2024 GoHealth, Inc.
October 1, 2024	EX-99.1	GoHealth Closes Acquisition of e-TeleQuote Acquisition Contributes Over $100 Million in Contract Assets plus $18 Million in Cash to Balance Sheet, and Expands Agent Capacity with a $5 Million Investment ahead of busy enrollment season CHICAGO, IL and GoHealth Closes Acquisition of e-TeleQuote Acquisition Contributes Over $100 Million in Contract Assets plus $18 Million in Cash to Balance Sheet, and Expands Agent Capacity with a $5 Million Investment ahead of busy enrollment season CHICAGO, IL and CLEARWATER, FL, October 1, 2024 – GoHealth, Inc.
September 30, 2024	CORRESP	Three months Jun. 30,2024 September 30, 2024 VIA EDGAR SUBMISSION Division of Corporate Finance U.S. Securities and Exchange Commission Washington, D.C. 20549 Attn: Joyce Sweeney and Kathleen Collins Re: GoHealth, Inc. Form 10-K for the Year Ended December 31, 2023 Form 10-Q for Quarterly Period Ended June 30, 2024 Response Dated July 19, 2024 File No. 001-39390 Dear Ms. Sweeney and Ms. Collins: On behalf of GoHealth, Inc.
September 4, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 30, 2024 GoHealth, Inc.
September 4, 2024	EX-99.1	1 GoHealth Acquiring e-TeleQuote, Strengthening Position as Leading Medicare Insurance Marketplace Investment further expands industry-leading shopping, enrollment, and engagement platform, delivering a differentiated experience and driving high qual 1 GoHealth Acquiring e-TeleQuote, Strengthening Position as Leading Medicare Insurance Marketplace Investment further expands industry-leading shopping, enrollment, and engagement platform, delivering a differentiated experience and driving high quality outcomes while ensuring peace of mind in Medicare consumers’ healthcare decisions.
August 8, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 8, 2024 GoHealth, Inc.
August 8, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
August 8, 2024	EX-99.1	Second Quarter Highlights Exhibit 99.1 GoHealth Reports Second Quarter 2024 Results CHICAGO, August 8, 2024 — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and six months ended June 30, 2024. Second Quarter Highlights •Second quarter 2024 net revenues of $105.9 million, a $36.9
July 31, 2024	CORRESP	222 W Merchandise Mart Plaza Ste 1740 \| Chicago, IL 60654 \| 1.888.250.3409 \| www.gohealth.com July 19, 2024 VIA EDGAR SUBMISSION Division of Corporate Finance U.S. Securities and Exchange Commission Washington, D.C. 20549 Attn: Joyce Sweeney and Kathleen Collins Re: GoHealth, Inc. Form 10-K for the Year Ended December 31, 2023 Form 8-K furnished May 9, 2024 File No. 001-39390 Dear Ms. Sweeney and Ms. Collins: On behalf of GoHealth, Inc. (the “Company”, “we”, “management”), I am hereby subm
July 19, 2024	CORRESP	222 W Merchandise Mart Plaza Ste 1740 \| Chicago, IL 60654 \| 1.888.250.3409 \| www.gohealth.com July 19, 2024 VIA EDGAR SUBMISSION Division of Corporate Finance U.S. Securities and Exchange Commission Washington, D.C. 20549 Attn: Joyce Sweeney and Kath 222 W Merchandise Mart Plaza Ste 1740 \| Chicago, IL 60654 \| 1.888.250.3409 \| www.gohealth.com July 19, 2024 VIA EDGAR SUBMISSION Division of Corporate Finance U.S. Securities and Exchange Commission Washington, D.C. 20549 Attn: Joyce Sweeney and Kathleen Collins Re: GoHealth, Inc. Form 10-K for the Year Ended December 31, 2023 Form 8-K furnished May 9, 2024 File No. 001-39390 Dear Ms. Sweeney and
July 10, 2024	EX-99.1	GoHealth Announces Changes to Board of Directors CHICAGO, July 10, 2024 /(GLOBE NEWSWIRE) — GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced changes to its B GoHealth Announces Changes to Board of Directors CHICAGO, July 10, 2024 /(GLOBE NEWSWIRE) — GoHealth, Inc.
July 10, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 8, 2024 GoHealth, Inc. (Exact UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 8, 2024 GoHealth, Inc.
June 26, 2024	CORRESP	SIDLEY AUSTIN LLP 1501 K STREET, N.W. WASHINGTON, D.C. 20005 +1 202 736 8000 +1 202 736 8711 FAX AMERICA • ASIA PACIFIC • EUROPE +1 202 736 8715 [email protected] Sidley Austin (DC) LLP is a Delaware limited liability partnership doing business gohealthcorrespextension SIDLEY AUSTIN LLP 1501 K STREET, N.W. WASHINGTON, D.C. 20005 +1 202 736 8000 +1 202 736 8711 FAX AMERICA • ASIA PACIFIC • EUROPE +1 202 736 8715 [email protected] Sidley Austin (DC) LLP is a Delaware limited liability partnership doing business as Sidley Austin LLP and practicing in affiliation with other Sidley Austin partnerships. June 26, 2024 VIA EDGAR U.S. Securi
June 25, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 25, 2024 GoHealth, Inc.
June 21, 2024	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 14, 2024 GoHealth, Inc.
June 14, 2024	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 12, 2024 GoHealth, Inc.
June 4, 2024	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 4, 2024 GoHealth, Inc.
June 4, 2024	EX-99.1	Katherine O'Halloran Appointed as Interim GoHealth Chief Financial Officer O'Halloran, current Chief Accounting Officer, brings 30 years of experience in Finance and Accounting at public and private companies Former CFO Jason Schulz departs for perso Katherine O'Halloran Appointed as Interim GoHealth Chief Financial Officer O'Halloran, current Chief Accounting Officer, brings 30 years of experience in Finance and Accounting at public and private companies Former CFO Jason Schulz departs for personal reasons after building high-performing finance organization during company turnaround Company to conduct search process for permanent CFO CHICAGO, June 4, 2024 /Globe Newswire/ — GoHealth, Inc.
May 9, 2024	EX-99.1	First Quarter Highlights Exhibit 99.1 GoHealth Reports First Quarter 2024 Results CHICAGO, May 9, 2024 — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three months ended March 31, 2024. First Quarter Highlights •First quarter 2024 net revenues of $185.6 million, a slight increase com
May 9, 2024	EX-10.2	Amended and Restated Employment Agreement signed May 8, 2024, by and among GoHealth, Inc., GoHealth Holdings, LLC, and Michael Hargis. 1 Amended and Restated Employment Agreement This Amended and Restated Employment Agreement (the “Agreement”), entered into as of May 1, 2024 is made by and between Michael Hargis (the “Executive”), GoHealth, Inc.
May 9, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
May 9, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2024 GoHealth, Inc.
April 26, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 26, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 20, 2024	S-8	As filed with the Securities and Exchange Commission on March 20, 2024 As filed with the Securities and Exchange Commission on March 20, 2024 Registration No.
March 20, 2024	EX-FILING FEES	Filing Fee Table Exhibit 107 CALCULATION OF FILING FEE TABLE FORM S-8 (Form Type) GOHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Table I: Newly Registered Securities Plan Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Amended and Restated 2020 Incentive
March 14, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
March 14, 2024	EX-99.1	Submissions Exhibit 99.1 GoHealth Reports Fourth Quarter and Fiscal 2023 Results CHICAGO, March 14, 2024 — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced unaudited financial results for the fourth quarter and year ended December 31, 2023. •The Company generated $109.1 million of cash flow from ope
March 14, 2024	EX-97.1	GoHealth, Inc. Policy on Recoupment of Incentive Compensation compensationclawbackpoli 1 GOHEALTH, INC. POLICY ON RECOUPMENT OF INCENTIVE COMPENSATION Introduction The Board of Directors (the “Board”) of GoHealth, Inc. (the “Company”) has adopted this Policy on Recoupment of Incentive Compensation (this “Policy”), which provides for the recoupment of compensation in certain circumstances in the event of a restatement of financial results by the Company. This
March 14, 2024	EX-99.1	Submissions Exhibit 99.1 GoHealth Reports Fourth Quarter and Fiscal 2023 Results CHICAGO, March 14, 2024 — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced unaudited financial results for the fourth quarter and year ended December 31, 2023. •The Company generated $109.1 million of cash flow from ope
March 14, 2024	EX-10.10	Amendment No. 11 to the Credit Agreement, dated as of March 12, 2024, among Norvax, LLC, as borrower, Blue Owl Capital Corporation, as administrative agent, collateral agent and required lenders. gohealth-amendmentno11a0 Execution Version AMENDMENT NO. 11 TO THE CREDIT AGREEMENT AMENDMENT NO. 11 TO THE CREDIT AGREEMENT, dated as of March 12, 2024 (this “Agreement”), by and among the Borrower (as defined below), each other Guarantor (as defined in the Credit Agreement) as of the date hereof, Holdings (as defined below), Blue Owl Capital Corporation (formerly known as Owl Rock Capital Corpor
March 14, 2024	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 14, 2024 GoHealth, Inc. (Ex UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 14, 2024 GoHealth, Inc.
March 14, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 14, 2024 GoHealth, Inc. (Exac UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 14, 2024 GoHealth, Inc.
March 14, 2024	EX-21.1	Subsidiaries of the Registrant Exhibit 21.1 Subsidiaries of GoHealth, Inc. Legal Name Jurisdiction of Incorporation or Organization GoHealth Holdings, LLC Delaware, USA Blizzard Midco, LLC Delaware, USA Norvax, LLC Delaware, USA GoHealth, LLC Delaware, USA Connected Benefits, LLC Delaware, USA GoHealth, s.r.o. Slovakia
November 9, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
November 9, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2023 GoHealth, Inc.
November 9, 2023	EX-99.1	Submissions Exhibit 99.1 GoHealth Reports Third Quarter 2023 Results CHICAGO, November 9, 2023 — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and nine months ended September 30, 2023. •Third quarter 2023 net revenues of $132.0 million, compared to $133.1 million i
August 25, 2023	SC 13D/A	GOCO / GoHealth Inc - Class A / NVX Holdings, Inc. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* GoHealth, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 38046W105 (CUSIP Number) Clinton P. Jones 214 West Huron St. Chicago, IL 60654 (312) 386-8200 (Name, Address and Telephone Number of Person A
August 25, 2023	SC 13D/A	GOCO / GoHealth Inc - Class A / Centerbridge Associates III, L.P. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* GoHealth, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 38046W105 (CUSIP Number) Susanne V. Clark c/o Centerbridge Partners, L.P. 375 Park Avenue, 11th Floor New York, NY 10152 (212) 672-5
August 10, 2023	EX-99.1	Submissions Exhibit 99.1 GoHealth Reports Second Quarter 2023 Results CHICAGO, August 10, 2023 — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and six months ended June 30, 2023. Second quarter 2023 net revenues of $142.8 million, a decrease of $15.9 million compar
August 10, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 10, 2023 GoHealth, Inc. (Exa UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 10, 2023 GoHealth, Inc.
August 10, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
August 10, 2023	EX-10.1	Separation and General Release Agreement, dated July 28, 2023, by and between Shane Cruz, Norvax, LLC, GoHealth, Inc., and GoHealth Holdings, LLC exhibit101 EX 10.1 SEPARATION AND GENERAL RELEASE AGREEMENT This Separation And General Release Agreement (this “Agreement”) is entered by and between Shane Cruz (“Executive”) and Norvax, LLC, GoHealth, Inc., a Delaware corporation (“GoHealth”), GoHealth Holdings, LLC, a Delaware limited liability company (the “Partnership” and, together with GoHealth and any of the Affiliates of GoHealth and the
June 6, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 6, 2023 GoHealth, Inc.
May 26, 2023	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 23, 2023 GoHealth, Inc.
May 19, 2023	EX-4	STRICTLY CONFIDENTIAL EX-4 EXHIBIT 4 STRICTLY CONFIDENTIAL May 18, 2023 The Board of Directors (the “Board”) GoHealth, Inc.
May 19, 2023	SC 13D/A	GOCO / GoHealth Inc - Class A / Centerbridge Associates III, L.P. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* GoHealth, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 38046W105 (CUSIP Number) Susanne V. Clark c/o Centerbridge Partners, L.P. 375 Park Avenue, 11th Floor New York, NY 10152 (212) 672-5
May 19, 2023	EX-4	Proposal dated May 18, 2023. EXHIBIT 4 STRICTLY CONFIDENTIAL May 18, 2023 The Board of Directors (the “Board”) GoHealth, Inc.
May 19, 2023	SC 13D/A	GOCO / GoHealth Inc - Class A / NVX Holdings, Inc. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* GoHealth, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 38046W105 (CUSIP Number) Clinton P. Jones 214 West Huron St. Chicago, IL 60654 (312) 386-8200 (Name, Address and Telephone Number of Person A
May 9, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
May 8, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2023 GoHealth, Inc.
May 8, 2023	EX-99.1	GoHealth Reports First Quarter 2023 Results Exhibit 99.1 GoHealth Reports First Quarter 2023 Results CHICAGO, May 8, 2023 — GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three months ended March 31, 2023. First quarter 2023 Trailing Twelve Months (“TTM”) positive cash flow from operations of $26.9 million compared to TTM negative c
April 11, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 11, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 23, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
March 23, 2023	EX-21.1	Subsidiaries of the Registrant Exhibit 21.1 Subsidiaries of GoHealth, Inc. Legal Name Jurisdiction of Incorporation or Organization GoHealth Holdings, LLC Delaware, USA Blizzard Midco, LLC Delaware, USA Norvax, LLC Delaware, USA GoHealth, LLC Delaware, USA Creatix, Inc. Illinois, USA Connected Benefits, LLC Delaware, USA GoHealth, s.r.o. Slovakia
March 17, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 15, 2023 GoHealth, Inc. (Exac UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 15, 2023 GoHealth, Inc.
March 17, 2023	EX-10.1	Amendment No. 10 to the Credit Agreement, dated as of March 15, 2023, among Norvax, LLC, as borrower, Owl Rock Capital Corporation, as administrative agent, collateral agent and required lenders. EX-10.1 Exhibit 10.1 Execution Version AMENDMENT NO. 10 TO THE CREDIT AGREEMENT AMENDMENT NO. 10 TO THE CREDIT AGREEMENT, dated as of March 15, 2023 (this “Agreement”), by and among the Borrower (as defined below), Owl Rock Capital Corporation (“Owl Rock”), in its capacity as the administrative agent (in such capacity, the “Administrative Agent”), and each of the Lenders signatory hereto constitut
March 16, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 16, 2023 GoHealth, Inc. (Exac UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 16, 2023 GoHealth, Inc.
March 16, 2023	EX-99.1	GoHealth Reports Fourth Quarter and Fiscal 2022 Results Exhibit 99.1 GoHealth Reports Fourth Quarter and Fiscal 2022 Results CHICAGO, March 16, 2023 — GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced unaudited financial results and select operating metrics for the fourth quarter and year ended December 31, 2022. Full year 2022 positive cash flow from operations of $60.9 m
February 14, 2023	SC 13G/A	US38046W2044 / GOHEALTH INC / HARRIS ASSOCIATES L P Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* GoHealth, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 38046W204 (CUSIP Number) December 31 , 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate
February 9, 2023	SC 13G/A	US38046W2044 / GOHEALTH INC / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0996-gohealthincclassa.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: GoHealth Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 38046W204 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to desig
January 19, 2023	EX-99.1	Exhibit 99.1 GoHealth Announces Strong Preliminary AEP Operating Results from Efficient Model and Expanded Encompass Solution Encompass-led business transformation drives operating efficiencies resulting in positive cash flow from operations for FY20 exhibit991 Exhibit 99.1 GoHealth Announces Strong Preliminary AEP Operating Results from Efficient Model and Expanded Encompass Solution Encompass-led business transformation drives operating efficiencies resulting in positive cash flow from operations for FY2022 GoHealth continues to be a leading producer for health plan partners, with increased conversion and effectuation rates during 2022 AEP C
January 19, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 17, 2023 GoHealth, Inc. (Ex UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 17, 2023 GoHealth, Inc.
January 13, 2023	S-8	As filed with the Securities and Exchange Commission on January 13, 2023 As filed with the Securities and Exchange Commission on January 13, 2023 Registration No.
January 13, 2023	EX-FILING FEES	Filing Fee Table exhibit107 Exhibit 107 CALCULATION OF FILING FEE TABLE FORM S-8 (Form Type) GOHEALTH, INC.
January 9, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 5, 2023 GoHealth, Inc. (Exa UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 5, 2023 GoHealth, Inc.
December 12, 2022	SC 13D/A	GOCO / GoHealth, Inc. Class A / CCP III Cayman GP Ltd. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* GoHealth, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 38046W105 (CUSIP Number) Susanne V. Clark c/o Centerbridge Partners, L.P. 375 Park Avenue, 11th Floor New York, NY 10152 (212) 672-5
December 7, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 5, 2022 GoHealth, Inc. (Ex UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 5, 2022 GoHealth, Inc.
December 2, 2022	SC 13D/A	GOCO / GoHealth, Inc. Class A / CCP III Cayman GP Ltd. - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* GoHealth, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 38046W105 (CUSIP Number) Susanne V. Clark c/o Centerbridge Partners, L.P. 375 Park Avenue, 11th Floor New York, NY 10152 (212) 672-5000 (Name
November 25, 2022	SC 13D	GOCO / GoHealth, Inc. Class A / NVX Holdings, Inc. - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* GoHealth, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 38046W105 (CUSIP Number) Clinton P. Jones 214 West Huron St. Chicago, IL 60654 (312) 386-8200 (Name, Address and Telephone Number of Pe
November 25, 2022	SC 13D	GOCO / GoHealth, Inc. Class A / CCP III Cayman GP Ltd. - SC 13D Activist Investment SC 13D 1 d379746dsc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* GoHealth, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 38046W105 (CUSIP Number) Susanne V. Clark c/o Centerbridge Partners, L.P. 375 Park Avenue, 11th Floor New Yo
November 25, 2022	EX-99.1	JOINT FILING AGREEMENT EX-99.1 EXHIBIT 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13D. Each of them is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning su
November 25, 2022	EX-99.1	Joint Filing Agreement. EX-99.1 EXHIBIT 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13D. Each of them is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning su
November 22, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 22, 2022 GoHealth, Inc. (E UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 22, 2022 GoHealth, Inc.
November 18, 2022	EX-3.1	Certificate of Amendment to Amended and Restated Certificate of Incorporation of GoHealth, Inc. Exhibit 3.1 CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF GOHEALTH, INC. GoHealth, Inc. (the ?Corporation?), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, hereby certifies as follows: 1. This Certificate of Amendment amends the provisions of the Corporation?s Amended and Restated Certificate of I
November 18, 2022	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2022 GOHEALTH, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39390 85-0563805 (State or other jurisdiction of incorporation) (Commission File N
November 15, 2022	SC 13G	GOCO / GoHealth, Inc. Class A / Anthem, Inc. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* GoHealth, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 38046W105 (CUSIP Number) September 23, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the
November 15, 2022	EX-99.1	JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to certain shares of the Class A common stock of GoHealth, Inc. and further agree that this Joint Filing Agreement shall be included
November 14, 2022	EX-10.1	Amendment No. 9 to the Credit Agreement, dated as of November 9, 2022, among Norvax, LLC, as borrower, Blizzard Midco, LLC, as a guarantor, the other guarantors party thereto, Owl Rock Capital Corporation, as administrative agent, collateral agent and swingline lender and the other lenders from time to time party thereto. 1 Exhibit 10.1 Execution Version AMENDMENT NO. 9 TO THE CREDIT AGREEMENT AMENDMENT NO. 9 TO THE CREDIT AGREEMENT, dated as of November 9, 2022 (this ?Agreement?), by and among each of the Lenders signatory hereto constituting the Required Lenders (each as defined in the Credit Agreement, as defined below), the Borrower (as defined below), Holdings (as defined below), each other Guarantor (as defin
November 14, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
November 10, 2022	EX-99.1	GoHealth Reports Third Quarter 2022 Results Exhibit 99.1 GoHealth Reports Third Quarter 2022 Results CHICAGO, November 10, 2022 ? GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and nine months ended September 30, 2022. YTD 2022 positive cash flow from operations of $101.9 million compared to negative cash flow from operations
November 10, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2022 GoHealth, Inc.
October 25, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 24, 2022 GOHEALTH, INC. (Ex UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 24, 2022 GOHEALTH, INC.
September 26, 2022	EX-10.3	Amendment No. 2 to the Second Amended and Restated Limited Liability Company Agreement of GoHealth Holdings, LLC, dated as of September 23, 2022 Exhibit 10.3 Execution Version AMENDMENT NO. 2 TO THE SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF GOHEALTH HOLDINGS, LLC This Amendment No. 2 to the Second Amended and Restated Limited Liability Company Agreement of GoHealth Holdings, LLC (including the exhibits hereto, this ?Amendment?) is effective as of September 23, 2022. Capitalized terms used in this Amendment that are
September 26, 2022	EX-99.1	GoHealth Receives $50 Million Strategic Investment to Support Long-Term Growth Opportunities Transaction further strengthens balance sheet and provides additional funding to invest in new technologies that will fuel the expansion of GoHealth’s benefi EX-99.1 Exhibit 99.1 GoHealth Receives $50 Million Strategic Investment to Support Long-Term Growth Opportunities Transaction further strengthens balance sheet and provides additional funding to invest in new technologies that will fuel the expansion of GoHealth’s beneficiary-centric enrollment and engagement platform CHICAGO, September 26, 2022 — GoHealth, Inc. (Nasdaq: GOCO), a leading health in
September 26, 2022	EX-10.1	Investment Agreement dated as of September 23, 2022 among GoHealth, Inc. and the purchasers identified therein. Exhibit 10.1 Execution Version INVESTMENT AGREEMENT by and among GOHEALTH, INC. and the PURCHASERS identified on Schedule 1 attached hereto Dated as of September 23, 2022 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 Section 1.01 Definitions 1 ARTICLE II SALE AND PURCHASE OF THE SHARES 10 Section 2.01 Sale and Purchase of the Shares 10 Section 2.02 Closing; Deliverables 10 Section 2.03 Use of Pro
September 26, 2022	EX-10.2	Registration Rights Agreement dated as of September 23, 2022 among GoHealth, Inc. and the persons identified therein. Exhibit 10.2 Execution Version REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this ?Agreement?) is made as of September 23, 2022 by and among GoHealth, Inc., a Delaware corporation (the ?Corporation?), and each Person listed on the signature pages hereto (such Persons, collectively, the ?Series A Investors?). RECITALS WHEREAS, the Corporation and the Series A Investors are parti
September 26, 2022	EX-3.1	Certificate of Designations of Series A Convertible Perpetual Preferred Stock of GoHealth, Inc. Exhibit 3.1 CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PERPETUAL PREFERRED STOCK, OF GOHEALTH, INC. Pursuant to Section 151 of the Delaware General Corporation Law (as amended, supplemented or restated from time to time, the ?DGCL?), GOHEALTH, INC., a corporation organized and existing under the laws of the State of Delaware (the ?Company?), in accordance with the provisions of Section 10
September 26, 2022	EX-3.2	Certificate of Designations of Series A-1 Convertible Non-Voting Perpetual Preferred Stock of GoHealth, Inc. Exhibit 3.2 CERTIFICATE OF DESIGNATIONS OF SERIES A-1 CONVERTIBLE NON-VOTING PERPETUAL PREFERRED STOCK, OF GOHEALTH, INC. Pursuant to Section 151 of the Delaware General Corporation Law (as amended, supplemented or restated from time to time, the ?DGCL?), GOHEALTH, INC., a corporation organized and existing under the laws of the State of Delaware (the ?Company?), in accordance with the provisions
September 26, 2022	8-K	Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 23, 2022 GOHEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-39390 85-0563805 (State or other jurisdiction of incorporation or organization) (
September 19, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.?) Filed by the Registrant ?? ? ? Filed by a Party other than the Registrant ?? Check the appropriate box: ?? Preliminary Proxy Statement ?? Confidential, for Use of the Commission Only (as permitted by
September 15, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 11, 2022 GOHEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-39390 85-0563805 (State or other jurisdiction of incorporation or organization) (
September 6, 2022	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ?? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi
August 16, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
August 16, 2022	EX-10.4	Separation Agreement, dated June 3, 2022, by and among GoHealth Inc., GoHealth Holdings, LLC, and Brandon Cruz Exhibit 10.4 June 3, 2022 Brandon Cruz [Via email] Re: Separation from Employment Dear Brandon: As we have discussed, this letter (this ?Letter?) confirms that your employment with GoHealth, Inc. (?GoHealth?) and GoHealth Holdings, LLC (the ?Partnership? and, together with GoHealth and any of the affiliates of GoHealth and the Partnership for which you provide or have provided services from time t
August 16, 2022	EX-10.2	Employment Agreement, dated June 3, 2022, by and among GoHealth, Inc., GoHealth Holdings, LLC, and Jason Schulz 1 Exhibit 10.2 Employment Agreement This Employment Agreement (the ?Agreement?), entered into as of June 3, 2022, is made by and between Jason Schulz (the ?Executive?), GoHealth, Inc., a Delaware corporation (?GoHealth?), and GoHealth Holdings, LLC, a Delaware limited liability company (the ?Partnership? and, together with GoHealth and any of the Affiliates of GoHealth and the Partnership as may e
August 16, 2022	EX-10.5	General Release Agreement, dated June 6, 2022, by and between James Sharman and Norvax, LLC Exhibit 10.5 SEPARATION AND GENERAL RELEASE AGREEMENT This Separation And General Release Agreement (this ?Agreement?) is entered by and between James Sharman (?Executive?) and Norvax, LLC, its direct and indirect parent, and each of its subsidiaries and affiliates (collectively, the ?Company?) (collectively, the ?Parties?). In consideration of the mutual promises contained herein, including but n
August 16, 2022	EX-10.6	GoHealth, Inc. Non-Employee Director Compensation Policy. 1 Exhibit 10.6 GOHEALTH, INC. NON?EMPLOYEE DIRECTOR COMPENSATION POLICY Non?employee members of the board of directors (the ?Board?) of GoHealth, Inc. (the ?Company?) shall be eligible to receive cash and equity compensation as set forth in this Non? Employee Director Compensation Policy (this ?Policy?). The cash and equity compensation described in this Policy shall be paid or be made, as applica
August 16, 2022	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ?Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Quarter Ended: June 30, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q For the Transition Period
August 16, 2022	EX-10.1	Employment Agreement, dated June 3, 2022, by and among GoHealth, Inc., GoHealth Holdings, LLC, and Vijay Kotte 1 US-DOCS\131055246.15 Exhibit 10.1 Employment Agreement This Employment Agreement (the ?Agreement?), entered into as of June 3, 2022, is made by and between Vijay Kotte (the ?Executive?), GoHealth, Inc., a Delaware corporation (?GoHealth?), and GoHealth Holdings, LLC, a Delaware limited liability company (the ?Partnership? and, together with GoHealth and any of the Affiliates of GoHealth and the
August 16, 2022	EX-10.3	Amended and Restated Employment Agreement, dated June 3, 2022, by and among GoHealth, Inc., GoHealth Holdings, LLC, and Clinton Jones 1 Exhibit 10.3 Amended and Restated Employment Agreement This Amended and Restated Employment Agreement (the ?Agreement?), entered into as of June 3, 2022, is made by and between Clinton Jones (the ?Executive?), GoHealth, Inc., a Delaware corporation (?GoHealth?), and GoHealth Holdings, LLC, a Delaware limited liability company (the ?Partnership? and, together with GoHealth and any of the Affiliat
August 15, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 15, 2022 GoHealth, Inc.
August 15, 2022	EX-99.1	GoHealth Reports Second Quarter 2022 Results Exhibit 99.1 GoHealth Reports Second Quarter 2022 Results CHICAGO, August 15, 2022 ? GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and six months ended June 30, 2022. Second quarter 2022 Medicare Submitted Policies of 177,911 increased 9% compared to the prior year period. YTD 2022
August 15, 2022	EX-10.1	Amendment No. 8 to the Credit Agreement, dated as of August 12, 2022, among Norvax, LLC, as borrower, Blizzard Midco, LLC, as a guarantor, the other guarantors party thereto, Owl Rock Capital Corporation, as administrative agent, collateral agent and swingline lender and the other lenders from time to time party thereto. Exhibit 10.1 Execution Version AMENDMENT NO. 8 TO THE CREDIT AGREEMENT AMENDMENT NO. 8 TO THE CREDIT AGREEMENT, dated as of August 12, 2022 (this ?Agreement?), by and among each of the Lenders signatory hereto constituting the Required Lenders (each as defined in the Credit Agreement, as defined below), the Borrower (as defined below), Holdings (as defined below), each other Guarantor (as defined
August 15, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 12, 2022 GoHealth, Inc.
July 14, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 8, 2022 GoHealth, Inc.
June 8, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 3, 2022 GoHealth, Inc.
June 6, 2022	EX-FILING FEES	Filing Fee Table Exhibit 107 CALCULATION OF FILING FEE TABLE FORM S-8 (Form Type) GOHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Table I: Newly Registered Securities Plan Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 2020 Incentive Award Plan Equity Cla
June 6, 2022	EX-99.4	Incentive Award Plan Form of Stock Appreciation Rights Grant Notice and Stock Appreciation Rights Agreement Exhibit 99.4 GOHEALTH, INC. 2020 INCENTIVE AWARD PLAN STOCK APPRECIATION RIGHTS GRANT NOTICE Capitalized terms not specifically defined in this Stock Appreciation Rights Grant Notice (the ?Grant Notice?) have the meanings given to them in the 2020 Incentive Award Plan (as may be amended from time to time, the ?Plan?) of GoHealth, Inc. (the ?Company?). The Company has granted to the participant lis
June 6, 2022	S-8	As filed with the Securities and Exchange Commission on June 6, 2022 As filed with the Securities and Exchange Commission on June 6, 2022 Registration No.
June 6, 2022	EX-99.6	First Amendment to the GoHealth, Inc. 2021 Inducement Award Plan Exhibit 99.6 FIRST AMENDMENT TO THE GOHEALTH, INC. 2021 INDUCEMENT AWARD PLAN This First Amendment (this ?First Amendment?) to the GoHealth, Inc. 2021 Inducement Award Plan (the ?Plan?) is adopted by the Board of Directors (the ?Board?) of GoHealth, Inc., a Delaware corporation (the ?Company?), on June 3, 2022. RECITALS A. The Company currently maintains the Plan. B. Pursuant to Section 12.1 of th
June 6, 2022	EX-99.8	Inducement Award Plan Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Agreement Exhibit 99.8 GOHEALTH, INC. 2021 INDUCEMENT AWARD PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE AND RESTRICTED STOCK UNIT AGREEMENT GoHealth, Inc., a Delaware corporation (the ?Company?), pursuant to its 2021 Inducement Award Plan, as amended from time to time (the ?Plan?), hereby grants to the holder listed below (?Participant?) the number of Restricted Stock Units set forth below (the ?RSUs?). T
June 6, 2022	EX-99.7	Inducement Award Plan Form of Stock Option Award Grant Notice and Stock Option Agreement Exhibit 99.7 GOHEALTH, INC. 2021 INDUCEMENT AWARD PLAN NOTICE OF STOCK OPTION GRANT Name of Participant: Address: Date of Grant: Exercise Price per Share: $ Total Number of Shares Subject to Option Granted: Type of Option: Nonstatutory Stock Option Expiration Date: Vesting Commencement Date: Vesting Schedule: This Option shall be exercisable, in whole or in part, according to the following vesting
May 27, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 25, 2022 GoHealth, Inc.
May 10, 2022	EX-10.2	Amended and Restated Employment Agreement, dated July 7, 2020, by and among GoHealth, Inc., GoHealth Holdings, LLC, and Brandon Cruz. US-DOCS\116795635.3 Exhibit 10.2 EXECUTION VERSION AMENDED & RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the ?Agreement?) dated as of July 6, 2020 (the ?Effective Date?) is made by and between Norvax, LLC (?Norvax?), GoHealth, Inc. (?GoHealth?), GoHealth Holdings, LLC (the ?Partnership? and, together with GoHealth and any of the Affiliates of GoHealth and the Part
May 10, 2022	EX-99.1	GoHealth Reports First Quarter 2022 Results Exhibit 99.1 GoHealth Reports First Quarter 2022 Results Reaffirms Full-Year Guidance CHICAGO, May 10, 2022 ? GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced financial results for the three months ended March 31, 2022. First quarter 2022 net revenue of $270.6 million increased 33% compared to the prior year period. First
May 10, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
May 10, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2022 GoHealth, Inc.
May 10, 2022	EX-10.3	Employment Agreement, dated June 3, 2020, by and among GoHealth, Inc., GoHealth Holdings, LLC, and Brian Farley. Exhibit 10.3 June 3, 2020 Brian Farley ### Dear Brian On behalf of Norvax, LLC/GoHealth, ("GoHealth" or the "Company") I am pleased to offer you the position of Chief Legal Officer and Corporate .Secretary of GoHealth with a scheduled start date of June 22, 2020 ("Start Date"). Your employment location will be Chicago, Illinois and you will rep01t to GoHealth's Chief Executive Officer. Your annual
May 5, 2022	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 29, 2022 GoHealth, Inc.
April 29, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 25, 2022 GoHealth, Inc.
April 13, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ? SCHEDULE 14A (Rule 14a-101) ? INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION ? Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 13, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) ? INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 8, 2022	SC 13G/A	GOCO / GoHealth, Inc. Class A / HARRIS ASSOCIATES L P Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* GOHEALTH INC (Name of Issuer) Class A Common Stock (Title of Class of Securities) 38046W105 (CUSIP Number) March 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched
April 8, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 5, 2022 GoHealth, Inc.
March 23, 2022	S-8	As filed with the Securities and Exchange Commission on March 23, 2022 As filed with the Securities and Exchange Commission on March 23, 2022 Registration No.
March 23, 2022	EX-FILING FEES	Filing Fee Table Exhibit 107 CALCULATION OF FILING FEE TABLE FORM S-8 (Form Type) GOHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Table I: Newly Registered Securities Plan Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 2020 Incentive Award Plan Equity Cla
March 16, 2022	EX-10.17	Employment Agreement, dated July 6, 2020, by and among GoHealth, Inc., GoHealth Holdings, LLC, and Travis Matthiesen; Amended Employment Agreement and Executive Common Unit and Profit Unit Agreement, dated October 18, 2021, by and among GoHealth, Inc., GoHealth Holdings, LLC, and Travis Matthiesen; and Second Employment Agreement Amendment, dated February 1 Exhibit 10.17 EXECUTION VERSION Employment Agreement This Employment Agreement (the ?Agreement?), entered into as of July 6, 2020, is made by and between Travis Matthiesen (the ?Executive?), GoHealth, Inc., a Delaware corporation (?GoHealth?), and GoHealth Holdings, LLC, a Delaware limited liability company (the ?Partnership? and, together with GoHealth and any of the Affiliates of GoHealth and
March 16, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
March 16, 2022	EX-21.1	Subsidiaries of the Registrant Exhibit 21.1 Subsidiaries of GoHealth, Inc. Legal Name Jurisdiction of Incorporation or Organization GoHealth Holdings, LLC Delaware, USA Blizzard Midco, LLC Delaware, USA Norvax, LLC Delaware, USA GoHealth, LLC Delaware, USA Creatix, Inc. Illinois, USA Connected Benefits, LLC Delaware, USA GoHealth, s.r.o. Slovakia
March 16, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 14, 2022 GoHealth, Inc.
March 16, 2022	EX-10.18	Employment Agreement, dated December 2, 2021, by and among GoHealth, Inc., GoHealth Holdings, LLC, and Vance Johnston Exhibit 10.18 EXECUTION VERSION Employment Agreement This Employment Agreement (the ?Agreement?), entered into as of December 2, 2021, is made by and between Vance Johnston (the ?Executive?), GoHealth, Inc., a Delaware corporation (?GoHealth?), and GoHealth Holdings, LLC, a Delaware limited liability company (the ?Partnership? and, together with GoHealth and any of the Affiliates of GoHealth and t
March 16, 2022	EX-10.1	Amendment No. 7 to the Credit Agreement and Incremental Facility Agreement, dated as of March 14, 2022, among Norvax, LLC, as borrower, Blizzard Midco, LLC, as a guarantor, the other guarantors party thereto, Owl Rock Capital Corporation, as administrative agent, collateral agent and swingline lender and the other lenders from time to time party thereto. Exhibit 10.1 Execution Version AMENDMENT NO. 7 TO THE CREDIT AGREEMENT AMENDMENT NO. 7 TO THE CREDIT AGREEMENT, dated as of March 14, 2022 (this ?Agreement?), by and among each of the Lenders signatory hereto constituting the Required Lenders (each as defined in the Credit Agreement, as defined below), the Borrower (as defined below), Holdings (as defined below), each other Guarantor (as defined i
March 15, 2022	EX-99.1	GoHealth Reports Fourth Quarter and Fiscal 2021 Results Exhibit 99.1 GoHealth Reports Fourth Quarter and Fiscal 2021 Results Focusing on Optimization in 2022 CHICAGO, March 15, 2022 ? GoHealth, Inc. (Nasdaq: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced financial results for the three and twelve months ended December 31, 2021. Fourth quarter 2021 net revenue of $449.6 million increased 1% compared
March 15, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 15, 2022 GoHealth, Inc.
March 2, 2022	EX-99.1	GoHealth Announces Preliminary Fourth Quarter and Year End 2021 Results Exhibit 99.1 GoHealth Announces Preliminary Fourth Quarter and Year End 2021 Results CHICAGO, March 1, 2022 ? GoHealth, Inc. (Nasdaq: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced today preliminary, unaudited financial results and select operating metrics for the fourth quarter and year ended December 31, 2021. Net revenue for the fourth quart
March 2, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 1, 2022 GoHealth, Inc.
March 2, 2022	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2021 ☐ T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: December 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q For the Transition Pe
February 14, 2022	SC 13G	GOCO / GoHealth, Inc. Class A / NVX Holdings, Inc. - SC 13G Passive Investment United States Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to ? 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to ? 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* GoHealth, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class o
February 14, 2022	EX-99.1	In accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998), this Statement is being filed by Credit Suisse AG (the "Bank"), a Swiss bank, on behalf of its subsidiaries to the extent that they conduct business as the In accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998), this Statement is being filed by Credit Suisse AG (the "Bank"), a Swiss bank, on behalf of its subsidiaries to the extent that they conduct business as the Swiss Universal Bank, Asia Pacific, International Wealth Management, Global Markets, Investment Banking & Capital Markets and the Strategic Resolutio
February 14, 2022	SC 13G/A	GOCO / GoHealth, Inc. Class A / CREDIT SUISSE AG/ - NONE Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* GoHealth, Inc. (Name of Issuer) Class A Common Stock,$0.0001 par value per share (Title of Class of Securities) 38046W105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the
February 11, 2022	SC 13G/A	GOCO / GoHealth, Inc. Class A / HARRIS ASSOCIATES L P Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* GOHEALTH INC (Name of Issuer) Class A Common Stock (Title of Class of Securities) 38046W105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc
February 10, 2022	SC 13G/A	GOCO / GoHealth, Inc. Class A / Centerbridge Associates III, L.P. - SC 13G/A Passive Investment SC 13G/A 1 d274117dsc13ga.htm SC 13G/A United States Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* GoHealth, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Securities) 38046W105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Che
February 10, 2022	EX-99	JOINT FILING AGREEMENT Exhibit 99 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13G.
February 10, 2022	SC 13G	GOCO / GoHealth, Inc. Class A / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: GoHealth Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 38046W105 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ R
January 28, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 24, 2022 GoHealth, Inc.
January 12, 2022	SC 13G/A	GOCO / GoHealth, Inc. Class A / Norwest Equity Partners IX, LP - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934* Under the Securities Exchange Act of 1934 (Amendment No. 1)* GoHealth, Inc. (Name of Issuer) Class A Common stock, $0.0001 par value per
January 12, 2022	EX-1	Joint Filing Agreement, dated January 12, 2022. EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G/A to which this Joint Filing Agreement is attached shall be filed by Norwest Equity Partners IX, LP on its own behalf and on behalf of (a) Itasca Partners IX, LLC, a Delaware limited liability company, (b) Norwest Venture Capital Management, Inc.
December 22, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 21, 2021 GoHealth, Inc.
December 20, 2021	EX-99.1	GoHealth, Inc. 2021 Inducement Award Plan Exhibit 99.1 GOHEALTH, INC. 2021 INDUCEMENT AWARD PLAN ARTICLE 1. PURPOSE The purpose of the GoHealth, Inc. 2021 Inducement Award Plan (as it may be amended or restated from time to time, the ?Plan?) is to promote the success and enhance the value of GoHealth, Inc. (the ?Company?) by linking the individual interests of Eligible Individuals to those of Company stockholders and by providing such ind
December 20, 2021	S-8	As filed with the Securities and Exchange Commission on December 20, 2021 As filed with the Securities and Exchange Commission on December 20, 2021 Registration No.
December 20, 2021	EX-99.2	Inducement Award Plan Form of Stock Option Award Grant Notice and Stock Option Agreement EX-99.2 5 d270006dex992.htm EX-99.2 Exhibit 99.2 GOHEALTH, INC. 2021 INDUCEMENT AWARD PLAN NOTICE OF STOCK OPTION GRANT Name of Participant: Address: Date of Grant: Exercise Price per Share: $ Total Number of Shares Subject to Option Granted: Type of Option: Nonstatutory Stock Option Expiration Date: Vesting Commencement Date: Vesting Schedule: This Option shall be exercisable, in whole or in part
December 20, 2021	EX-99.3	Inducement Award Plan Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Agreement EX-99.3 6 d270006dex993.htm EX-99.3 Exhibit 99.3 GOHEALTH, INC. 2021 INDUCEMENT AWARD PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE AND RESTRICTED STOCK UNIT AGREEMENT GoHealth, Inc., a Delaware corporation (the “Company”), pursuant to its 2021 Inducement Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (“Participant”) the number of Restricted Stock U
December 10, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 6, 2021 GoHealth, Inc.
November 10, 2021	EX-10.1	Amendment No. 6 to the Credit Agreement and Incremental Facility Agreement, dated as of November 10, 2021, among Norvax, LLC, as borrower, Blizzard Midco, LLC, as a guarantor, the other guarantors party thereto, Owl Rock Capital Corporation, as administrative agent, collateral agent and swingline lender and the other lenders from time to time party thereto. 1 US-DOCS\127562975.9 Exhibit 10.1 Execution Version AMENDMENT NO. 6 TO THE CREDIT AGREEMENT AND INCREMENTAL FACILITY AGREEMENT AMENDMENT NO. 6 TO THE CREDIT AGREEMENT AND INCREMENTAL FACILITY AGREEMENT, dated as of November 10, 2021 (this ?Agreement?), by and among the persons signatory hereto as 2021-2 Incremental Term Lenders (the ?2021-2 Incremental Term Lenders?), each of the Lenders signator
November 10, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
November 10, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2021 GoHealth, Inc.
November 9, 2021	EX-99.1	GoHealth Reports Third Quarter 2021 Results Exhibit 99.1 GoHealth Reports Third Quarter 2021 Results Reaffirms Full-Year Guidance CHICAGO, November 9, 2021 ? GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced financial results for the three and nine months ended September 30, 2021. Third quarter 2021 net revenue of $211.7 million increased 30% compared to the prior ye
November 9, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2021 GoHealth, Inc.
October 20, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 18, 2021 GoHealth, Inc.
August 30, 2021	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 26, 2021 GoHealth, Inc. (Exa UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 26, 2021 GoHealth, Inc.
August 12, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
August 11, 2021	EX-99.1	GoHealth Reports Second Quarter 2021 Results Exhibit 99.1 GoHealth Reports Second Quarter 2021 Results Revises Full Year 2021 Growth Outlook CHICAGO, August 11, 2021 ? GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced financial results for the three and six months ended June 30, 2021. Second quarter 2021 net revenue of $196.9 million increased 55% compared to the prio
August 11, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 11, 2021 GoHealth, Inc.
June 14, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 11, 2021 GoHealth, Inc.
June 14, 2021	EX-10.1	, 2021, among Norvax, LLC, as borrower, Blizzard Midco, LLC, as a guarantor, the other guarantors party thereto, Owl Rock Capital Corporation, as administrative agent, collateral agent and swingline lender and the other lenders from time to time party thereto. Exhibit 10.1 Execution Version AMENDMENT NO. 5 TO THE CREDIT AGREEMENT AND INCREMENTAL FACILITY AGREEMENT AMENDMENT NO. 5 TO THE CREDIT AGREEMENT AND INCREMENTAL FACILITY AGREEMENT, dated as of June 11, 2021 (this ?Agreement?), by and among the persons signatory hereto as Amendment No. 5 Revolving Lenders (each a ?Amendment No. 5 Revolving Lender? and, collectively, the ?Amendment No. 5 Revolving
June 10, 2021	SC 13G	GOCO / GoHealth, Inc. Class A / HARRIS ASSOCIATES L P Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* GOHEALTH INC (Name of Issuer) Class A Common Stock (Title of Class of Securities) 38046W105 (CUSIP Number) May 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule
May 28, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 26, 2021 Date of Report (Date of earliest event reported) GOHEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-39390 85-0563805 (State or Other Jurisdiction of Incorporation) (Commission File Number)
May 13, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
May 13, 2021	EX-10.2	Amendment No. 4 to the Credit Agreement and Incremental Facility Agreement, dated as of May 7, 2021, among Norvax, LLC, as borrower, Blizzard Midco, LLC, as a guarantor, the other guarantors party thereto, Owl Rock Capital Corporation, as administrative agent, collateral agent and swingline lender and the other lenders from time to time party thereto. Exhibit 10.2 Execution Version 1 US-DOCS\116356604.4 AMENDMENT NO. 4 TO THE CREDIT AGREEMENT AND INCREMENTAL FACILITY AGREEMENT AMENDMENT NO. 4 TO THE CREDIT AGREEMENT and INCREMENTAL FACILITY AGREEMENT, dated as of May 7, 2021 (this ?Agreement?), by and among the persons signatory hereto as Incremental No. 4 Revolving Lenders (each a ?Incremental No. 4 Revolving Lender? and, collectively, the ?In
May 13, 2021	EX-10.1	Amendment No. 1 to Second Amended and Restated Limited Liability Company Agreement of GoHealth Exhibit 10.1 US-DOCS\121695209.2 AMENDMENT NO. 1 TO THE SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF GOHEALTH HOLDINGS, LLC This AMENDMENT No. 1, dated as of March 9, 2021 (this ?Amendment?), to the Second Amended and Restated Limited Liability Company Agreement (as amended, the ?LLC Agreement?) of GoHealth Holdings, LLC, a Delaware limited liability company (the ?Company?),
May 12, 2021	EX-99.1	GoHealth Reports First Quarter 2021 Results EX-99.1 2 goco-20210331xexhibit991.htm EX-99.1 GoHealth Reports First Quarter 2021 Results Reaffirms Full Year 2021 Growth Outlook CHICAGO, May 12, 2021 — GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced financial results for the three months ended March 31, 2021. First quarter 2021 net revenue of $204.2 million increased
May 12, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 12, 2021 GoHealth, Inc.
April 6, 2021	DEF 14A	Definitive Proxy Statement TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 6, 2021	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
March 16, 2021	EX-4.2	Description of Registrant’s Securities Exhibit 4.2 Description of the Registrant?s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 DESCRIPTION OF CAPITAL STOCK General Our amended and restated certificate of incorporation authorizes capital stock consisting of: ?1,100,000,000 shares of Class A common stock, par value $0.0001 per share; ?690,000,000 shares of Class B common stock, par value $0.0001 pe
March 16, 2021	EX-21.1	Subsidiaries of the Registrant EX-21.1 3 goco-20201231xex211xform10.htm EX-21.1 Exhibit 21.1 Subsidiaries of GoHealth, Inc. Legal Name Jurisdiction of Incorporation or Organization GoHealth Holdings, LLC Delaware, USA Blizzard Midco, LLC Delaware, USA Norvax, LLC Delaware, USA GoHealth, LLC Delaware, USA Creatix, Inc. Illinois, USA Connected Benefits, LLC Delaware, USA GoHealth, s.r.o. Slovakia
March 16, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
March 8, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 8, 2021 GoHealth, Inc.
March 8, 2021	EX-99.1	GoHealth Reports Fourth Quarter and Fiscal 2020 Results EX-99.1 2 goco-20201231xexhibit991.htm EX-99.1 Exhibit 99.1 GoHealth Reports Fourth Quarter and Fiscal 2020 Results Expects Continued Strong Growth in 2021 CHICAGO, March 8, 2021 — GoHealth, Inc. (Nasdaq: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced financial results for the three and twelve months ended December 31, 2020. Fourth quarter 2020
February 16, 2021	SC 13G/A	SCHEDULE 13G/A INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934* (Amendment No. 1) GoHealth, Inc. (Name of Issuer) Common stock, $ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934* (Amendment No. 1) GoHealth, Inc. (Name of Issuer) Common stock, $0.001 par value per share (Title of Class of Securities) 38046W105 (CUSIP Numb
February 12, 2021	SC 13G	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* GoHealth, Inc. (Name of Issuer) Class A Common Stock,$0.0001 par value per share (Title of Class of S Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* GoHealth, Inc. (Name of Issuer) Class A Common Stock,$0.0001 par value per share (Title of Class of Securities) 38046W105 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box t
February 12, 2021	EX-99.1	In accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998), this Statement is being filed by Credit Suisse AG (the "Bank"), a Swiss bank, on behalf of its subsidiaries to the extent that they conduct business as the In accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998), this Statement is being filed by Credit Suisse AG (the "Bank"), a Swiss bank, on behalf of its subsidiaries to the extent that they conduct business as the Swiss Universal Bank, Asia Pacific, International Wealth Management, Global Markets, Investment Banking & Capital Markets and the Strategic Resolutio
February 11, 2021	EX-99	JOINT FILING AGREEMENT EX-99 Exhibit 99 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13G.
February 11, 2021	SC 13G	United States Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SC 13G United States Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* GoHealth, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of C
February 10, 2021	S-8	- S-8 S-8 As filed with the Securities and Exchange Commission on February 10, 2021 Registration No.
February 10, 2021	8-K	Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 9, 2021 GoHealth, Inc.
February 9, 2021	SC 13G	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934* Under the Securities Exchange Act of 1934 GoHealth, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Class of Se
February 4, 2021	EX-99	JOINT FILING AGREEMENT EX-99 Exhibit 99 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13G.
February 4, 2021	SC 13G	United States Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SC 13G United States Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* GoHealth, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of C
November 13, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
November 12, 2020	EX-99.1	GoHealth Reports Third Quarter 2020 Results and Increases 2020 Outlook As a Result of Strong Medicare Enrollments and Operating Leverage EX-99.1 Exhibit 99.1 GoHealth Reports Third Quarter 2020 Results and Increases 2020 Outlook As a Result of Strong Medicare Enrollments and Operating Leverage CHICAGO, November 11, 2020 — GoHealth, Inc. (GoHealth or the Company) (Nasdaq: GOCO), a leading health insurance marketplace, announced financial results for the three and nine months ended September 30, 2020. • Third quarter 2020 net revenue
November 12, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 11, 2020 GoHealth, Inc.
August 20, 2020	EX-10.2	Incremental Facility Agreement and Technical Amendment No. 3 to Credit Agreement, dated as of June 11, 2020, among Norvax, LLC, as borrower, Blizzard Midco, LLC, as a guarantor, the other guarantors party thereto, Owl Rock Capital Corporation, as administrative agent, collateral agent and swingline lender and the other lenders from time to time party thereto. EX-10.2 Exhibit 10.2 Execution Version INCREMENTAL FACILITY AGREEMENT NO. 3 TO CREDIT AGREEMENT INCREMENTAL FACILITY AGREEMENT NO. 3, dated as of June 11, 2020 (this “Agreement”), by and among the persons signatory hereto as Incremental No. 3 Revolving Lenders (each a “Incremental No. 3 Revolving Lender” and, collectively, the “Incremental No. 3 Revolving Lenders”), the Borrower (as defined below)
August 20, 2020	10-Q	Quarterly Report - 10-Q 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc.
August 20, 2020	EX-3.2	Amended and Restated Bylaws of GoHealth, Inc. EX-3.2 Exhibit 3.2 Execution AMENDED AND RESTATED BYLAWS OF GOHEALTH, INC. Dated as of July 15, 2020 1 CONTENTS Page Article I. Meetings of Stockholders 1 Section 1.01 Place of Meetings 1 Section 1.02 Annual Meetings 1 Section 1.03 Special Meetings 1 Section 1.04 Notice of Meetings 1 Section 1.05 Adjournments 2 Section 1.06 Quorum 2 Section 1.07 Organization 2 Section 1.08 Voting; Proxies 3 Sectio
August 20, 2020	EX-3.1	Amended and Restated Certificate of Incorporation of GoHealth, Inc. EX-3.1 Exhibit 3.1 Execution AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF GOHEALTH, INC. GoHealth, Inc., a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows: 1. The original Certificate of Incorporation of the Corporation was filed with the Office of the Secretary of State of the State of Delaware on March 27, 2020 (the “Original Certif
August 19, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 19, 2020 GoHealth, Inc.
August 19, 2020	EX-99.1	GoHealth Reports Second Quarter 2020 Results and Provides 2020 Outlook Growth Fueled by Strong Medicare Advantage Enrollments EX-99.1 Exhibit 99.1 GoHealth Reports Second Quarter 2020 Results and Provides 2020 Outlook Growth Fueled by Strong Medicare Advantage Enrollments CHICAGO, August 19, 2020 — GoHealth, Inc. (“GoHealth”) (Nasdaq: GOCO), a leading health insurance marketplace, announced financial results for the three and six months ended June 30, 2020. • Second quarter 2020 net revenues of $127.1 million increased 7
July 27, 2020	SC 13G	GOCO / GoHealth, Inc. Class A / Viking Global Investors LP - ACQUISITION OF BENEFICIAL OWNERSHIP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934* GoHealth, Inc. (Name of Issuer) Common stock, $0.001 par value per share (Title of Class of Securities) 38046W105 (CUSIP Number) July 16, 2020 (D
July 17, 2020	EX-10.2	Registration Rights Agreement, dated July 15, 2020, by and among GoHealth, Inc. and each other person identified on the schedule of investors attached thereto. EX-10.2 Exhibit 10.2 Execution Version REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of July 15, 2020 by and among GoHealth, Inc., a Delaware corporation (the “Corporation”), and each Person identified on the Schedule of Holders attached hereto as of the date hereof (such Persons, collectively, the “Original Equity Owner Parties”). RECITALS WHEREAS,
July 17, 2020	EX-10.3	Second Amended and Restated Limited Liability Company Agreement of GoHealth, LLC, dated July 15, 2020, by and among GoHealth, LLC and its Members. EX-10.3 Exhibit 10.3 Execution GOHEALTH HOLDINGS, LLC SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT Dated as of July 15, 2020 THE LIMITED LIABILITY COMPANY INTERESTS REPRESENTED BY THIS SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR UNDER ANY OTHER APPLICABLE SECURITIES LAWS.
July 17, 2020	EX-10.4	Stockholders Agreement, dated July 15, 2020, by and among GoHealth, Inc. and the persons and entities listed on the schedules attached thereto. EX-10.4 Exhibit 10.4 Execution STOCKHOLDERS AGREEMENT OF GOHEALTH, INC. THIS STOCKHOLDERS AGREEMENT, dated as of July 15, 2020 (as it may be amended, amended and restated or otherwise modified from time to time in accordance with the terms hereof, this “Agreement”), is entered into by and among GoHealth, Inc., a Delaware corporation (the “Corporation”), Centerbridge Capital Partners III, L.P., a D
July 17, 2020	EX-10.1	Tax Receivable Agreement, dated July 15, 2020, by and among the GoHealth, Inc., GoHealth, LLC, CB Blizzard Co-Invest Holdings, L.P., CCP III AIV VII Holdings, L.P. and each of the Members from time to time party thereto. EX-10.1 Exhibit 10.1 Execution Version TAX RECEIVABLE AGREEMENT by and among GOHEALTH, INC. GOHEALTH HOLDINGS, LLC and THE SEVERAL TRA HOLDERS (AS DEFINED HEREIN) FROM TIME TO TIME PARTY HERETO Dated as of July 15, 2020 TABLE OF CONTENTS Page ARTICLE I Definitions SECTION 1.1. Definitions 3 SECTION 1.2. Rules of Construction 13 ARTICLE II Determination of Realized Tax Benefit SECTION 2.1. Basis Ad
July 17, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 15, 2020 GoHealth, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-39390 85-0563805 (State or Other Jurisdiction of Incorporation) (Commission File N
July 16, 2020	424B4	43,500,000 Shares GoHealth, Inc. Class A Common Stock 424B4 Table of Contents Filed Pursuant to Rule 424(b)(4) Registration Nos. 333-239287 and 333-239861 43,500,000 Shares GoHealth, Inc. Class A Common Stock This is an initial public offering of shares of Class A common stock of GoHealth, Inc. We are selling 43,500,000 shares of Class A common stock. Prior to this offering, there has been no public market for the Class A common stock. We have been a
July 15, 2020	EX-4.2	Form of Amended and Restated Bylaws of GoHealth, Inc., to be effective immediately prior to the completion of the initial public offering. EX-4.2 Exhibit 4.2 AMENDED AND RESTATED BYLAWS OF GOHEALTH, INC. Dated as of July 15, 2020 CONTENTS Page Article I. Meetings of Stockholders 1 Section 1.01 Place of Meetings 1 Section 1.02 Annual Meetings 1 Section 1.03 Special Meetings 1 Section 1.04 Notice of Meetings 1 Section 1.05 Adjournments 2 Section 1.06 Quorum 2 Section 1.07 Organization 2 Section 1.08 Voting; Proxies 3 Section 1.09 Fixin
July 15, 2020	S-8	- S-8 S-8 As filed with the Securities and Exchange Commission on July 15, 2020 Registration No.
July 15, 2020	EX-4.1	Form of Amended and Restated Certificate of Incorporation of GoHealth, Inc., to be effective immediately prior to the completion of the initial public offering. EX-4.1 Exhibit 4.1 Execution AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF GOHEALTH, INC. GoHealth, Inc., a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows: 1. The original Certificate of Incorporation of the Corporation was filed with the Office of the Secretary of State of the State of Delaware on March 27, 2020 (the “Original Certif
July 15, 2020	8-A12B	Form 8-A 8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 GoHealth, Inc. (Exact name of registrant as specified in its charter) Delaware 85-0563805 (State or incorporation or organization) (I.R.S. Employer Identification No.) 214 West Huron St. Chi

GOCO / GoHealth, Inc. - SEC Filings, Annual Report, Proxy Statement

Basic Stats

SEC Filings

SEC Filings (Chronological Order)